CV Lattes
GoogleMyCitations
ORCID
Universidade Estadual de Campinas (UNICAMP). Faculdade de Ciências Médicas (FCM) (Institutional affiliation for the last research proposal) Birthplace: Brazil
graduation at Medicina from Universidade Estadual de Campinas (2000) and doctorate at Neurologia from Universidade Estadual de Campinas (2008). Has experience in Medicine, focusing on Medicine, acting on the following subjects: cefaléia trigêmino-autonômica and pupila de argyll robertson. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Alzheimer´s disease (AD) is the most common neurodegenerative disorder and its prevalence is increasing mainly due to the aging of the population. Recent clinical trials with anti-amyloid and other drugs in AD dementia and Mild Cognitive Impairment (MCI) have failed, and one possible explanation is that diagnosis is made too late, when subjects have already relevant clinical symptoms. Thu…
Alzheimer's disease (AD) is among the most prevalent clinical conditions, mostly due to the population ageing. Also, among the most prevalent diseases, AD is the only which does not have effective prevention and treatment. One of the most relevant aspects in AD research is the development of biomarkers to characterize this disease in its earlier stage, aiming a better pharmacological mana…
Suspected Non-Alzheimer Pathophysiology (SNAP) is a biomarker-based concept whose underlying pathological causes have not yet been understood. It refers to individuals with negative levels of B-amyloid biomarkers, but in whom biomarkers of neurodegeneration and/or p-Tau are positive. SNAP causes great interest in research, as it is unclear whether it should be considered an independent cl…
Mild Cognitive Impairment (CCL) and Subjective Cognitive Decline (DCS) are considered possible preclinical indicators of Alzheimer's Disease (AD). Thus, the risks of increased conversion rate (10 to 15% per year) for prevalence are higher in patients with these conditions. Given this, increase the need for studies that previously alter consultations, to aid in early diagnosis and thus inc…
Alzheimer's disease (AD) is a neurodegenerative condition of relevant social and economicimpacts and its early diagnosis is essential to improve the prognosis of patients. Thus, theseeking for promising new techniques in the investigation of early markers of the disease is ofparamount importance. In this paper, a relatively new technique will be applied in the study ofAD alterations, an a…
Alzheimer´s Disease (AD) is the most common neurodegenerative disorder and itsprevalence is increasing mainly due to the aging of the population. Recent clinical trials withanti-amyloid and other drugs in AD Dementia and Mild Cognitive Impairment (MCI) havefailed, and one possible explanation is that diagnosis is made too late, when subjects havealready relevant clinical symptoms. Thus, t…
The most common type of dementia is Alzheimer's Disease (AD), and currently there are more than 60 million people diagnosed with AD in the world. This disease affects the cognition, behavior and independence of the individual, generating major impacts on society and becoming a public health problem. Some of the major pathological features of AD can be evaluated through biomarkers, such as…
(Only some records are available in English at this moment)
Alzheimer's disease (AD) dementia is a neurodegenerative disease characterized by progressive brain atrophy and cognitive decline. Although AD is defined by the excessive amount of neuritic plaques and neurofibrillary tangles, the complete neurodegenerative process is much more complex and not fully understood. The most accepted models of AD progression indicate that pathophysiological ch…
Alzheimer's disease (AD) is a degenerative disorder that causes cognitive impairment and dependence in activities of daily life. Amnestic Mild Cognitive Impairment (aMCI) is a term used to diagnose patients with clinical decline in memory and with or without more cognitive domains, but with normal social and functional performance. These patients have a greater chance of developing AD. Ar…
Recent research in the Alzheimer's disease (AD) neuroimaging field has moved beyond regional alterations, raising the concept of dysfunctionality of brain networks to explain the cognitive and clinical symptoms of AD patients. Amongst all networks investigated in the AD field, the Default Mode Network (DMN) is undoubtedly the most studied, and several studies show a breakdown in its funct…
| 1 / 1 | Ongoing research grants |
| 4 / 3 | Completed research grants |
| 2 / 2 | Ongoing scholarships in Brazil |
| 15 / 15 | Completed scholarships in Brazil |
| 3 / 3 | Completed scholarships abroad |
| 25 / 24 | All research grants and scholarships |
| Associated processes | |
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
| Publications | 12 |
| Citations | 168 |
| Cit./Article | 14.0 |
| Data from Web of Science | |
RABELO, ANA G. B.; TEIXEIRA, CAMILA V. L.; MAGALHAES, THAMIRES N. C.; CARLETTI-CASSANI, ANA FLAVIA M. K.; AMATO FILHO, AUGUSTO C. S.; JOAQUIM, HELENA P. G.; TALIB, LEDA L.; FORLENZA, ORESTES; RIBEIRO, PATRICIA A. O.; SECOLIN, RODRIGO; et al. Is cerebral microbleed prevalence relevant as a biomarker in amnestic mild cognitive impairment and mild Alzheimer's disease?. NEURORADIOLOGY JOURNAL, v. 30, n. 5, p. 477-485, OCT 2017. Web of Science Citations: 2. (13/07559-3, 14/25429-2)
BALTHAZAR, MARCIO L. F.; PEREIRA, FABRICIO R. S.; LOPES, TATILA M.; DA SILVA, ELVIS L.; COAN, ANA CAROLINA; CAMPOS, BRUNNO M.; DUNCAN, NIALL W.; STELLA, FLORINDO; NORTHOFF, GEORG; DAMASCENO, BENITO P.; et al. Neuropsychiatric Symptoms in Alzheimer's Disease Are Related to Functional Connectivity Alterations in the Salience Network. Human Brain Mapping, v. 35, n. 4, p. 1237-1246, APR 2014. Web of Science Citations: 64. (09/02179-2)
WEILER, MARINA; NORTHOFF, GEORG; DAMASCENO, BENITO PEREIRA; FIGUEREDO BALTHAZAR, MARCIO LUIZ. Self, cortical midline structures and the resting state: Implications for Alzheimer's disease. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, v. 68, p. 245-255, SEP 2016. Web of Science Citations: 8. (13/10431-9)
RIZZI, LIARA; AVENTURATO, ITALO KARMANN; BALTHAZAR, MARCIO L. F.. Neuroimaging Research on Dementia in Brazil in the Last Decade: Scientometric Analysis, Challenges, and Peculiarities. FRONTIERS IN NEUROLOGY, v. 12, MAR 15 2021. Web of Science Citations: 0. (18/15571-7, 19/23028-4)
FIGUEREDO BALTHAZAR, MARCIO LUIZ; DE CAMPOS, BRUNNO MACHADO; FRANCO, ALEXANDRE ROSA; DAMASCENO, BENITO PEREIRA; CENDES, FERNANDO. Whole cortical and default mode network mean functional connectivity as potential biomarkers for mild Alzheimer's disease. PSYCHIATRY RESEARCH-NEUROIMAGING, v. 221, n. 1, p. 37-42, JAN 30 2014. Web of Science Citations: 27. (11/17092-0)
WEILER, MARINA; FUKUDA, AYA; MASSABKI, LILIAN H. P.; LOPES, TATILA M.; FRANCO, ALEXANDRE R.; DAMASCENO, BENITO P.; CENDES, FERNANDO; BALTHAZAR, MARCIO L. F.. Default Mode, Executive Function, and Language Functional Connectivity Networks are Compromised in Mild Alzheimer's Disease. Current Alzheimer Research, v. 11, n. 3, p. 274-282, MAR 2014. Web of Science Citations: 18. (13/10431-9, 11/17092-0)
THAÍS T. HAYATA; FELIPE P. G. BERGO; THIAGO J. REZENDE; ALFREDO DAMASCENO; BENITO P. DAMASCENO; FERNANDO CENDES; FLORINDO STELLA; MARCIO L. F. BALTHAZAR. Cortical correlates of affective syndrome in dementia due to Alzheimer’s disease. Arquivos de Neuro-Psiquiatria, v. 73, n. 7, p. -, Jul. 2015. (12/08291-1, 11/17092-0)
HAYATA, THAIS T.; BERGO, FELIPE P. G.; REZENDE, THIAGO J.; DAMASCENO, ALFREDO; DAMASCENO, BENITO P.; CENDES, FERNANDO; STELLA, FLORINDO; BALTHAZAR, MARCIO L. F.. Cortical correlates of affective syndrome in dementia due to Alzheimer's disease. Arquivos de Neuro-Psiquiatria, v. 73, n. 7, p. 553-560, JUL 2015. Web of Science Citations: 5. (11/17092-0, 12/08291-1)
FIGUEREDO BALTHAZAR, MARCIO LUIZ; YASUDA, CLARISSA LIN; SILVESTRE PEREIRA, FABRICIO RAMOS; GUAZZI BERGO, FELIPE PAULO; CENDES, FERNANDO; DAMASCENO, BENITO PEREIRA. Coordinated and circumlocutory semantic naming errors are related to anterolateral temporal lobes in mild AD, amnestic mild cognitive impairment, and normal aging. Journal of the International Neuropsychological Society, v. 16, n. 6, p. 1099-1107, NOV 2010. Web of Science Citations: 6. (09/02179-2)
PEDRO, TATIANE; WEILER, MARINA; YASUDA, CLARISSA L.; D'ABREU, ANELYSSA; DAMASCENO, BENITO P.; CENDES, FERNANDO; BALTHAZAR, MARCIO L. F.. Volumetric Brain Changes in Thalamus, Corpus Callosum and Medial Temporal Structures: Mild Alzheimer's Disease Compared with Amnestic Mild Cognitive Impairment. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, v. 34, n. 3-4, p. 149-155, 2012. Web of Science Citations: 15. (09/02179-2)
WEILER, MARINA; DE CAMPOS, BRUNNO MACHADO; NOGUEIRA, MATEUS HENRIQUE; DAMASCENO, BENITO PEREIRA; CENDES, FERNANDO; BALTHAZAR, MARCIO L. F.. Structural connectivity of the default mode network and cognition in Alzheimer's disease. PSYCHIATRY RESEARCH-NEUROIMAGING, v. 223, n. 1, p. 15-22, JUL 30 2014. Web of Science Citations: 13. (13/10431-9, 11/17092-0)
DE OLIVEIRA, TASSIA R.; ERBERELI, CAMILA R.; MANZINE, PATRICIA R.; MAGALHAES, THAMIRES N. C.; BALTHAZAR, MARCIO L. F.; COMINETTI, MARCIA R.; FARIA, RONALDO C.. Early Diagnosis of Alzheimer's Disease in Blood Using a Disposable Electrochemical Microfluidic Platform. ACS SENSORS, v. 5, n. 4, p. 1010-1019, APR 24 2020. Web of Science Citations: 7. (17/24839-0, 17/24053-7, 15/26084-1, 18/15571-7, 14/22401-0, 15/19890-1)
WEILER, MARINA; DE CAMPOS, BRUNNO MACHADO; DE LIGO TEIXEIRA, CAMILA VIEIRA; CASSEB, RAPHAEL FERNANDES; MAC KNIGHT CARLETTI-CASSANI, ANA FLAVIA; VICENTINI, JESSICA ELIAS; CARDOSO MAGALHAES, THAMIRES NAELA; TALIB, LEDA LEME; FORLENZA, ORESTES VICENTE; FIGUEREDO BALTHAZAR, MARCIO LUIZ. Intranetwork and internetwork connectivity in patients with Alzheimer disease and the association with cerebrospinal fluid biomarker levels. JOURNAL OF PSYCHIATRY & NEUROSCIENCE, v. 42, n. 6, p. 366-377, NOV 2017. Web of Science Citations: 3. (13/10431-9)
(References retrieved automatically from State of São Paulo Research Institutions)
BALTHAZAR, Marcio Luiz Figueredo. Perfusão por ressonância magnética (arterial spin labeling) em pacientes com doença de Alzheimer leve e comprometimento cognitivo leve e sua relação com o desempenho cognitivo. Dissertação (Mestrado) - Faculdade de Ciências Médicas (FCM). Universidade Estadual de Campinas (UNICAMP). (11/17092-0)
TEIXEIRA, Camila Vieira Ligo. Treinamento multifuncional em sujeitos com comprometimento cognitivo leve amnéstico com evidência fisiopatológica da doença de Alzheimer = efeitos em parâmetros clínicos e de neuroimagem funcional e estrutural. Tese (Doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas. (14/02359-9)
None